Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel

BACKGROUND: Although peripheral blood-based parameters (PBBPs) are reported as prognostic indicators in patients with breast cancers, their utility has not been studied in human epidermal growth factor receptor 2 (HER2)-positive advanced breast cancer (ABC). Tumor-infiltrating lymphocytes (TILs) mig...

Descripción completa

Detalles Bibliográficos
Autores principales: Araki, Kazuhiro, Ito, Yoshinori, Fukada, Ippei, Kobayashi, Kokoro, Miyagawa, Yoshimasa, Imamura, Michiko, Kira, Ayako, Takatsuka, Yuichi, Egawa, Chiyomi, Suwa, Hirofumi, Ohno, Shinji, Miyoshi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191898/
https://www.ncbi.nlm.nih.gov/pubmed/30326862
http://dx.doi.org/10.1186/s12885-018-4888-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191898/
https://www.ncbi.nlm.nih.gov/pubmed/30326862
http://dx.doi.org/10.1186/s12885-018-4888-2

Ejemplares similares